Synergistic Infection
Synergistic Infection - Related Videos
01:33
Synergistic Photobiomodulation with a Dual-Wavelength Laser in an In Vitro Disease Model
0 Views •
2025
Divide the transwell system into five groups that undergo various treatments.The first group serves as the control and consists of a co-culture of neuroblastoma and microglia cells.In the second group, treat the co-culturer with fibrillar β-amyloid (fAβ) alone. fAβ induces damage in neuroblastoma cells.In the third group, treat neuroblastoma cells with an 808-nanometer laser, then co-culture them with untreated microglia.The laser reduces oxidative stress, improving neuronal survival.In the...
02:25
Synergistic Effect of Intracranial and Intraperitoneal Delivery of Analgesic Drugs on Thermal Pain Response in a Rat
0 Views •
2025
Source: Martinez, E., et al. Intracranial Pharmacotherapy and Pain Assays in Rodents. J. Vis. Exp. (2019).This video demonstrates the intracranial administration of an analgesic drug in an anesthetized rat with a pre-implanted guide cannula in the prefrontal cortex. An additional analgesic drug is co-administered intraperitoneally. Following recovery, the rat’s thermal pain response is assessed using Hargreave’s apparatus, where paw withdrawal latency is measured to evaluate the analgesic...
05:57
The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
0 Views •
Cited by 8 •
2013
We show that a developed biomedical device involving continuous or pulsed visible laser based treatment that is combined with antibiotic treatment (gentamycin), results in a statistically significant synergistic effect leading to a reduction in the viability of P. aeruginosa PAO1, by 8 log's compared to antibiotic treatment alone.
01:23
Synergistic Antimicrobial Effect of Membrane-Targeting Compounds on Antibiotic-Resistant Bacteria
0 Views •
2026
Take suspensions of an antibiotic-resistant strain of a pathogenic bacterium.Treat one suspension with a short, membrane-disrupting antibiotic compound and the other with both the short compound and a longer, membrane-intercalating compound.Incubate both suspensions with agitation. These compounds mimic the lipid bilayer structure, enabling their spontaneous insertion into bacterial membranes.The short compound spans only part of the membrane’s thickness, creating a structural mismatch. This...
12:30
Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
0 Views •
Cited by 108 •
2013
The larva of the wax moth Galleria mellonella was recently established as an in vivo model to study Legionella pneumophila infection. Here, we demonstrate fundamental techniques to characterize the pathogenesis of Legionella in the larvae, including inoculation, measurement of bacterial virulence and replication as well as extraction and analysis of infected hemocytes.
FAQs
One pathogen can increase the other’s impact by altering host immunity, damaging tissue, or changing the local environment. These changes may make a previously less favorable setting more permissive to replication, while the combined infection intensifies inflammation or disrupts organ function. The important point is that interaction changes the disease process, rather than simply adding two independent effects.
Host immunity can serve as a connecting mechanism between infectious agents. If the first infection changes immune activity, the host may respond differently to the second, affecting pathogen replication and inflammatory injury. Studying these immune changes helps explain why disease progression may diverge from what would be expected from either infection considered separately.
Tissue damage can promote synergy by altering the local conditions that surround an infection. Damage may change the environment in ways that support another agent or amplify inflammation. In immunology and infection research, examining tissue effects alongside replication and organ function helps distinguish a direct pathogen interaction from a disease process driven mainly by host or tissue changes.
Synergistic infection should be evaluated against the effects of each agent alone, not only by observing whether both are present. The relevant comparison asks whether coinfection changes replication, inflammation, or organ function beyond the single-agent patterns. This framework helps researchers identify an interaction and avoid attributing every severe outcome to one pathogen without examining the combined system.
A basic research workflow compares separate infections with the combined condition while tracking disease-relevant outcomes. Measurements can include pathogen replication, inflammatory responses, tissue or organ effects, and changes in host immunity. This comparison provides a structured way to determine which component changes during coinfection and whether the interaction is associated with greater disease severity.
Diagnosis becomes more difficult when the clinical picture reflects interacting agents rather than one infection in isolation. Research on synergistic infection therefore considers how coinfection may influence disease progression and immune responses, while supporting approaches that recognize pathogen interactions. This perspective can improve interpretation when observed inflammation, replication, or organ dysfunction does not fit a single-agent explanation.
Treatment research benefits from considering the interaction itself, not only selecting separate responses to each pathogen. If one agent changes immunity or tissue conditions in a way that affects the other, an intervention directed at only one component may not address the full disease process. Studying these relationships can guide therapeutic strategies designed around the combined infection and its effects.